Production of proinsulin by entrapped bacteria with control of cell division by inhibitors of DNA synthesis.
D000818:Animals; D001412:Bacillus subtilis / Q000187:drug effects / Q000235:genetics* / Q000254:growth & development; D002455:Cell Division / Q000187:drug effects; D004261:DNA Replication / Q000187:drug effects*; D004926:Escherichia coli / Q000187:drug effects / Q000235:genetics* / Q000254:growth & development; D005285:Fermentation; D006801:Humans; D006906:Hydroxyphenylazouracil / Q000494:pharmacology*; D009268:Nalidixic Acid / Q000494:pharmacology*; D009675:Novobiocin / Q000494:pharmacology*; D010957:Plasmids; D011384:Proinsulin / Q000096:biosynthesis / Q000235:genetics*; D051381:Rats; D011994:Recombinant Proteins / Q000096:biosynthesis; D014498:Uracil / Q000031:analogs & derivatives*
D011994:Recombinant Proteins; D009675:Novobiocin; D006906:Hydroxyphenylazouracil; D009268:Nalidixic Acid; D014498:Uracil; D011384:Proinsulin